ERO1LB antibody (AA 101-400)
Quick Overview for ERO1LB antibody (AA 101-400) (ABIN7152004)
Target
See all ERO1LB AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 101-400
-
Cross-Reactivity
- Human, Mouse
-
Purification
- >95%, Protein G purified
-
Immunogen
- Recombinant Human ERO1-like protein beta protein (101-400AA)
-
Isotype
- IgG
-
-
-
-
Application Notes
- Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- ERO1LB (ERO1-Like beta (ERO1LB))
-
Alternative Name
- ERO1B
-
Background
-
Background: Oxidoreductase involved in disulfide bond formation in the endoplasmic reticulum. Efficiently reoxidizes P4HB/PDI, the enzyme catalyzing protein disulfide formation, in order to allow P4HB to sustain additional rounds of disulfide formation. Other protein disulfide isomerase family members can also be reoxidized, but at lower rates compared to P4HB, including PDIA2 (50 % of P4HB reoxidation rate), as well as PDIA3, PDIA4, PDIA6 and NXNDC12 (<10 %). Following P4HB reoxidation, passes its electrons to molecular oxygen via FAD, leading to the production of reactive oxygen species (ROS) in the cell. May be involved in oxidative proinsulin folding in pancreatic cells, hence may play a role in glucose homeostasis.
Aliases: Endoplasmic oxidoreductin-1-like protein B antibody, Endoplasmic reticulum oxidoreductin-1-like protein B antibody, ERO1, S. cerevisiae, homolog of, beta antibody, ERO1-L-beta antibody, ERO1-like beta (S. cerevisiae) antibody, ERO1-like protein beta antibody, ERO1B_HUMAN antibody, Ero1lb antibody, Oxidoreductin-1-L-beta antibody
-
UniProt
- Q86YB8
-
Pathways
- SARS-CoV-2 Protein Interactome
Target
-